High triglyceride causes: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) |
Ochuko Ajari (talk | contribs) |
||
Line 29: | Line 29: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Dermatologic''' | | '''Dermatologic''' | ||
|bgcolor="Beige"| [[Systemic | |bgcolor="Beige"| [[Systemic lupus erythematosus]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[Amprenavir]], [[atazanavir|atazanavir sulfate]], [[atypical antipsychotics]], [[bendrofluazide]], [[beta-blockers]], [[bexarotene]], [[chlorthalidone]], [[clomiphene]], [[colesevelam|colesevelam hydrochloride]], [[colestyramine]], [[combined oral contraceptive | |bgcolor="Beige"| [[Amprenavir]], [[atazanavir|atazanavir sulfate]], [[atypical antipsychotics]], [[bendrofluazide]], [[beta-blockers]], [[bexarotene]], [[chlorthalidone]], [[clomiphene]], [[colesevelam|colesevelam hydrochloride]], [[colestyramine]], [[combined oral contraceptive pill]], [[desvenlafaxine]], [[diuretics]], [[estrogen replacement therapy]], [[fosamprenavir]], [[glucocorticoids]], [[hydrochlorothiazide]], [[interferon alpha]], [[linagliptin]], [[lopinavir]], [[mirtazapine]], [[non-nucleoside reverse transcriptase inhibitors]], [[olanzapine]], [[isotretinoin|oral isotretinoin]], [[propofol]], [[protease inhibitors]], [[ritonavir]], [[saquinavir]], [[tamoxifen]], [[temsirolimus]], [[tipranavir]], [[tocilizumab]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 53: | Line 53: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| [[Alagille syndrome]], [[Alström syndrome]], [[apolipoprotein E|apoprotein E deficiency]], [[carnitine palmitoyltransferase 1 deficiency]], [[cholesteryl ester storage disease]], [[congenital generalized | |bgcolor="Beige"| [[Alagille syndrome]], [[Alström syndrome]], [[apolipoprotein E|apoprotein E deficiency]], [[carnitine palmitoyltransferase 1 deficiency]], [[cholesteryl ester storage disease]], [[congenital generalized lipodystrophy|congenital generalized lipodystrophy type 1]], [[apolipoprotein C2|deficiency of apolipoprotein C2 ]], [[familial chylomicronemia]], [[familial combined hyperlipidemia]], [[familial histiocytic reticulosis]], [[familial hypertriglyceridemia]], [[fish eye disease]], [[glycogen storage disease|glycogen storage disease type 1]], [[glycogenosis type 1a]], [[hyperlipoproteinemia type V|hyperlipoproteinemia, familial type 5]], [[lecithin cholesterol acyltransferase deficiency]], [[metabolic syndrome]], [[Niemann-Pick disease|Niemann-Pick disease type B]], [[reaven syndrome|Reaven syndrome X]], [[sphingomyelinase deficiency]], [[Tangier disease]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| [[Familial | |bgcolor="Beige"| [[Familial histiocytic reticulosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
|bgcolor="Beige"| [[Parenteral | |bgcolor="Beige"| [[Parenteral nutrition]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 73: | Line 73: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| [[Niemann-Pick disease|Niemann-Pick disease type B]], [[sphingomyelinase | |bgcolor="Beige"| [[Niemann-Pick disease|Niemann-Pick disease type B]], [[sphingomyelinase deficiency]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| [[Alcohol]], [[apolipoprotein E|apoprotein E deficiency]], [[high chylomicron|chylomicron levels raised (plasma)]], [[apolipoprotein C2|deficiency of apolipoprotein C2]], [[familial | |bgcolor="Beige"| [[Alcohol]], [[apolipoprotein E|apoprotein E deficiency]], [[high chylomicron|chylomicron levels raised (plasma)]], [[apolipoprotein C2|deficiency of apolipoprotein C2]], [[familial chylomicronemia]], [[familial combined hyperlipidemia]], [[familial hypertriglyceridemia]], [[glycogen storage disease|glycogen storage disease type 1]], [[glycogenosis type 1a]], [[carbohydrate|high carbohydrate or high glycemic index]], [[hyperlipoproteinemia type V|hyperlipoproteinemia, familial type 5]], [[IDL|intermediate density lipoprotein levels raised (plasma or serum)]], [[lipodystrophy]], [[lipoprotein lipase deficiency]], [[metabolic syndrome]], [[obesity]], [[reaven syndrome|Reaven syndrome X]], [[Tangier disease]], [[VLDL|very low density lipoprotein levels raised (plasma or serum)]], [[vitamin E deficiency|vitamin E deficiency, familial isolated]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| [[Polycystic | |bgcolor="Beige"| [[Polycystic ovary syndrome]], [[pregnancy]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 89: | Line 89: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Ophthalmologic''' | | '''Ophthalmologic''' | ||
|bgcolor="Beige"| [[Diabetes | |bgcolor="Beige"| [[Diabetes mellitus]], [[Lecithin cholesterol acyltransferase deficiency]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 105: | Line 105: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Renal/Electrolyte''' | | '''Renal/Electrolyte''' | ||
|bgcolor="Beige"| [[Chronic | |bgcolor="Beige"| [[Chronic kidney disease]], [[chronic renal insufficiency]], [[diabetes mellitus]], [[nephrotic syndrome]], [[systemic lupus erythematosus]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" |
Revision as of 16:32, 25 September 2013
Triglyceride Microchapters |
Clinical Correlation |
---|
Treatment |
Case Studies |
High triglyceride causes On the Web |
American Roentgen Ray Society Images of High triglyceride causes |
Risk calculators and risk factors for High triglyceride causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]
Overview
Hypertriglyceridemia can occur due to various causes, including genetics, familial, metabolic and drugs
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 Kolovou GD, Anagnostopoulou KK, Kostakou PM, Bilianou H, Mikhailidis DP (2009). "Primary and secondary hypertriglyceridaemia". Curr Drug Targets. 10 (4): 336–43. PMID 19355858.
- ↑ Fallat RW, Glueck CJ (1976). "Familial and acquired type V hyperlipoproteinemia". Atherosclerosis. 23 (1): 41–62. PMID 1078394.